BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24466261)

  • 1. Diversity of virulence phenotypes among type III secretion negative Pseudomonas aeruginosa clinical isolates.
    Toska J; Sun Y; Carbonell DA; Foster AN; Jacobs MR; Pearlman E; Rietsch A
    PLoS One; 2014; 9(1):e86829. PubMed ID: 24466261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
    Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
    Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DeaD contributes to Pseudomonas aeruginosa virulence in a mouse acute pneumonia model.
    Tan H; Zhang L; Zhao Q; Chen R; Liu C; Weng Y; Peng Q; Bai F; Cheng Z; Jin S; Wu W; Jin Y
    FEMS Microbiol Lett; 2016 Oct; 363(20):. PubMed ID: 27682417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An indirect enzyme-linked immunosorbent assay for rapid and quantitative assessment of Type III virulence phenotypes of Pseudomonas aeruginosa isolates.
    Li L; Ledizet M; Kar K; Koski RA; Kazmierczak BI
    Ann Clin Microbiol Antimicrob; 2005 Dec; 4():22. PubMed ID: 16375761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exoenzyme Y Contributes to End-Organ Dysfunction Caused by
    Wagener BM; Anjum N; Christiaans SC; Banks ME; Parker JC; Threet AT; Walker RR; Isbell KD; Moser SA; Stevens T; Alexeyev MF; Audia JP; Richter W; Hardy KS; Saleh LA; Morgan C; Pittet JF
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32512716
    [No Abstract]   [Full Text] [Related]  

  • 6. The importance of the Pseudomonas aeruginosa type III secretion system in epithelium traversal depends upon conditions of host susceptibility.
    Sullivan AB; Tam KP; Metruccio MM; Evans DJ; Fleiszig SM
    Infect Immun; 2015 Apr; 83(4):1629-40. PubMed ID: 25667266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Primed Subpopulation of Bacteria Enables Rapid Expression of the Type 3 Secretion System in Pseudomonas aeruginosa.
    Lin CK; Lee DSW; McKeithen-Mead S; Emonet T; Kazmierczak B
    mBio; 2021 Jun; 12(3):e0083121. PubMed ID: 34154400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference of Type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media.
    Park MH; Kim SY; Roh EY; Lee HS
    Auris Nasus Larynx; 2017 Jun; 44(3):258-265. PubMed ID: 27461174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotype and toxicity of the recently discovered exlA-positive Pseudomonas aeruginosa strains collected worldwide.
    Reboud E; Elsen S; Bouillot S; Golovkine G; Basso P; Jeannot K; Attrée I; Huber P
    Environ Microbiol; 2016 Oct; 18(10):3425-3439. PubMed ID: 26914644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type III secretion system and virulence markers highlight similarities and differences between human- and plant-associated pseudomonads related to Pseudomonas fluorescens and P. putida.
    Mazurier S; Merieau A; Bergeau D; Decoin V; Sperandio D; Crépin A; Barbey C; Jeannot K; Vicré-Gibouin M; Plésiat P; Lemanceau P; Latour X
    Appl Environ Microbiol; 2015 Apr; 81(7):2579-90. PubMed ID: 25636837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of ExoS on
    Kroken AR; Chen CK; Evans DJ; Yahr TL; Fleiszig SMJ
    mBio; 2018 May; 9(3):. PubMed ID: 29717012
    [No Abstract]   [Full Text] [Related]  

  • 12. Cheating by type 3 secretion system-negative Pseudomonas aeruginosa during pulmonary infection.
    Czechowska K; McKeithen-Mead S; Al Moussawi K; Kazmierczak BI
    Proc Natl Acad Sci U S A; 2014 May; 111(21):7801-6. PubMed ID: 24821799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome Sequences of Two Pseudomonas aeruginosa Isolates with Defects in Type III Secretion System Gene Expression from a Chronic Ankle Wound Infection.
    Karash S; Nordell R; Ozer EA; Yahr TL
    Microbiol Spectr; 2021 Sep; 9(1):e0034021. PubMed ID: 34259549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The small RNA PrrH aggravates
    Shi Q; Zeng S; Yu R; Li M; Shen C; Zhang X; Zhao C; Zeng J; Huang B; Pu J; Chen C
    Microbiol Spectr; 2024 Mar; 12(3):e0062623. PubMed ID: 38289930
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of Type III Secretion Effectors and of Phenoxyacetamide Inhibitors of Type III Secretion on Abscess Formation in a Mouse Model of Pseudomonas aeruginosa Infection.
    Berube BJ; Murphy KR; Torhan MC; Bowlin NO; Williams JD; Bowlin TL; Moir DT; Hauser AR
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807906
    [No Abstract]   [Full Text] [Related]  

  • 16. The Pseudomonas aeruginosa periplasmic protease CtpA can affect systems that impact its ability to mount both acute and chronic infections.
    Seo J; Darwin AJ
    Infect Immun; 2013 Dec; 81(12):4561-70. PubMed ID: 24082078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SuhB is a regulator of multiple virulence genes and essential for pathogenesis of Pseudomonas aeruginosa.
    Li K; Xu C; Jin Y; Sun Z; Liu C; Shi J; Chen G; Chen R; Jin S; Wu W
    mBio; 2013 Oct; 4(6):e00419-13. PubMed ID: 24169572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A type III secretion negative clinical strain of Pseudomonas aeruginosa employs a two-partner secreted exolysin to induce hemorrhagic pneumonia.
    Elsen S; Huber P; Bouillot S; Couté Y; Fournier P; Dubois Y; Timsit JF; Maurin M; Attrée I
    Cell Host Microbe; 2014 Feb; 15(2):164-76. PubMed ID: 24528863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa Antivirulence Strategies: Targeting the Type III Secretion System.
    Goldberg JB; Crisan CV; Luu JM
    Adv Exp Med Biol; 2022; 1386():257-280. PubMed ID: 36258075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
    Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A;
    Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.